Tofacitinib Dihydro Impurity
| Product Name | Tofacitinib Dihydro Impurity |
|---|---|
| Alternate Names | Tofacitinib Impurities, Impurities of Tofacitinib |
| CAT No. | CS-T-89311 |
| CAS No. | 1640972-35-5 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 314.39 g/mol |
| Mol. For. | C₁₆H₂₂N₆O |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tofacitinib |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | N#CCC(N1C[C@H](N(C2=C3C(NCC3)=NC=N2)C)[C@H](C)CC1)=O |
| Canonical Smiles | CC1CCN(CC1N(C)C2=NC=NC3=C2CCN3)C(=O)CC#N |
| InchIKey | PEURVXMHTIUQCG-UHFFFAOYSA-N |
| Inchl | InChI=1S/C16H22N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h10-11,13H,3-5,7-9H2,1-2H3,(H,18,19,20) |
| IUPAC | 3-[3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
5,6-Dihydro Tofacitinib, also known as Tofacitinib citrate or Xeljanz, is a drug used in the treatment of rheumatoid arthritis and psoriatic arthritis. It belongs to the class of Janus kinase (JAK) inhibitors, which block the activity of enzymes responsible for inflammation and joint damage.
Chemically, 5,6-Dihydro Tofacitinib is a white to off-white crystalline powder, soluble in water and ethanol. It has a molecular weight of 504.9 g/mol and a chemical formula of C16H20N6O•C6H8O7.
The recommended dosage of 5,6-Dihydro Tofacitinib is 5 to 10 mg, taken orally twice daily with or without food. It is important to follow the dosage instructions provided by a healthcare professional to avoid any potential side effects.
Studies have shown that 5,6-Dihydro Tofacitinib is an effective treatment option for patients with rheumatoid arthritis and psoriatic arthritis, with significant improvement in symptoms such as joint pain, swelling, and stiffness. However, it is important to note that this drug may also have potential side effects such as infections, increased risk of cancer, and liver damage.
In conclusion, 5,6-Dihydro Tofacitinib is a potent drug used in the treatment of arthritis with a mechanism of action that targets enzymes responsible for inflammation. It is important to use this drug under the guidance of a healthcare professional and monitor potential side effects to ensure its safe and effective use.
Get an Instant Quote
Related Compounds
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide | Tofacitinib impurity Z | Tofacitinib impurity T | Tofacitinib impurity I | Tofacitinib impurity G | Tofacitinib N-hydroxy impurity | Tofacitinib impurity V | Tofacitinib- Keto Impurity | N,4-dimethyl-1-nitrosopiperidin-3-amine | Tofacitinib Impurity 16 | N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide | Tofacitinib formyl impurity | Tofacitinib impurity C | N-methyl-N-(4-methylpyridin-3-yl)nitrous amide | Tofacitinib Nitroso Impurity | Tofacitinib N- acid Impurity | Tofacitinib Nitroso Impurity 5 | Tofacitinib Diastereomer-1 and 2 | N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide | Tofacitinib N-oxide | Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) | Tofacitinib Nitroso Impurity 1 | Tofacitinib impurity P | Tofacitinib Nitroso Impurity 3 | Tofacitinib Related Compound 26 HCl | Tofacitinib impurity K | TOFACITINIB IMPURITY TOF-IV | Tofacitinib S,S Isomer | Tofacitinib Nitroso Impurity 4 | Tofacitinib impurity N | N-Nitroso Tofacitinib Amine Impurity | Tofacitinib Impurity 6 | Tofacitinib impurity J | Tofacitinib N-Nitroso benzyl intermediate | Tofacitinib Impurity 29 | Tofacitinib Hydroxy Impurity | Tofacitinib Diastereomer | Tofacitinib Impurity 57 | Tofacitinib Impurity 36 | Tofacitinib Nitroso Impurity 2 | Tofacitinib butyl ester impurity | Tofacitinib related compound 6 | Tofacitinib Dihydro Citricacid salt impurity | Tofacitinib Related Compound 29 |